search Result

Trump 2.0 may boost Indian pharma opportunities

Experts highlight that higher tariffs on Chinese goods might enable Indian firms to fill supply gaps in the US generic drug market, a critical region that accounts for 30% of Indian pharma sales and 40% of global volume share.Read more

India’s pharma sector likely to double post US Biosecure Act

At present, China’s CDMO industry commands 8% global market share compared to India’s 2.7%. Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016